| Product NDC: | 43063-239 |
| Proprietary Name: | Metaxalone |
| Non Proprietary Name: | Metaxalone |
| Active Ingredient(s): | 800 mg/1 & nbsp; Metaxalone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 43063-239 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA013217 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20071101 |
| Package NDC: | 43063-239-40 |
| Package Description: | 40 TABLET in 1 BOTTLE, PLASTIC (43063-239-40) |
| NDC Code | 43063-239-40 |
| Proprietary Name | Metaxalone |
| Package Description | 40 TABLET in 1 BOTTLE, PLASTIC (43063-239-40) |
| Product NDC | 43063-239 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Metaxalone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20071101 |
| Marketing Category Name | NDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | METAXALONE |
| Strength Number | 800 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |